title: [Clinico-diagnostic significance of high-molecular mucin CA19-9 blood level in patients with breast diseases].
abstract: Blood samples of 212 patients with breast lesions (32 patients had benign lesions and 180 - malignant breast tumors) were analyzed. Benign breast diseases corresponded to fabroadenoma, cyst and diffuse mastopathy. Among those with breast cancer I-IIa stages of the disease was diagnosed in 80 patients, IIb - in 34, IIIa and IIIb stages - in 9 and 38 cases, correspondingly, stage IV was diagnosed in 19 patients. 24 women aged younger then 35 years were diagnosed with breast cancer, 108 patients aged 36-55 years, 48 women were older then 56 years. Statistically significant increase of CA 19-9 was registered in 58,3 patients younger then 35 years, whereas in patients of older groups the significant increase of the tumor marker blood level was noticed only in 22,6%.
authors.forename: S K
authors.initials: SK
authors.lastname: Dzhubalieva
authors.forename: K K
authors.initials: KK
authors.lastname: Pugachev
authors.forename: T L
authors.initials: TL
authors.lastname: Khamann
authors.forename: Ch K
authors.initials: ChK
authors.lastname: Mustafin
authors.forename: A B
authors.initials: AB
authors.lastname: Katkov
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood*; D001941:Breast Diseases / Q000097:blood / Q000175:diagnosis*; D018395:CA-19-9 Antigen / Q000097:blood*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008875:Middle Aged; D015203:Reproducibility of Results
chemical_list: D015415:Biomarkers; D018395:CA-19-9 Antigen